Knight to Present at the 2021 Bloom Burton & Co. Healthcare Virtual Investor Conference Medical Device Investing
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer Biotech Investing
Champignon Brands, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm Psychedelics Investing
Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With Meibomian Gland Dysfunction Medical Device Investing
Better Plant Announces Agreement with Faire Wholesale Marketplace for Jusu Home and Body Products Cannabis Investing News
SHRMF BREAKING NEWS: ROSEN, A LEADING LAW FIRM, Encourages Champignon Brands Inc. Investors to Secure Counsel Before Important Deadline - SHRMF Psychedelics Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Champignon Brands Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm Psychedelics Investing
Have You Suffered Significant Losses Investing In Champignon Brands Inc.? Kehoe Law Firm, P.C. Securities Class Action Investigation Psychedelics Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
